These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25610190)

  • 1. Cases of Brainstem Infarcts after Cessation of Heparin Treatment: is it a Rebound Effect?
    Demir CF; Surgun F; Ozdemir H; Kapan O
    Eurasian J Med; 2011 Dec; 43(3):186-8. PubMed ID: 25610190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of pulmonary thromboembolism after interruption of treatment with unfractionated heparin].
    Paglia I; Carrieri L; Oliaro E; Bergerone S; Mangiardi L; Trevi GP
    Minerva Cardioangiol; 2002 Aug; 50(4):379-82. PubMed ID: 12147970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
    Lauer MA; Houghtaling PL; Peterson JG; Granger CB; Bhatt DL; Sapp SK; Simoons ML; Harrington RA; Topol EJ; Lincoff AM;
    Circulation; 2001 Dec; 104(23):2772-7. PubMed ID: 11733393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.
    Granger CB; Miller JM; Bovill EG; Gruber A; Tracy RP; Krucoff MW; Green C; Berrios E; Harrington RA; Ohman EM
    Circulation; 1995 Apr; 91(7):1929-35. PubMed ID: 7895349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions.
    Watkins MW; Luetmer PA; Schneider DJ; Witmer WT; Vaitkus PT; Sobel BE
    Cathet Cardiovasc Diagn; 1998 Jul; 44(3):257-64. PubMed ID: 9676792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: results from the Thrombolysis in Myocardial Infarction (TIMI) 11B and Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) studies.
    Bijsterveld NR; Peters RJ; Murphy SA; Bernink PJ; Tijssen JG; Cohen M
    J Am Coll Cardiol; 2003 Dec; 42(12):2083-9. PubMed ID: 14680731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: potential mechanisms for heightened prothrombotic potential.
    Becker RC; Spencer FA; Li Y; Ball SP; Ma Y; Hurley T; Hebert J
    J Am Coll Cardiol; 1999 Oct; 34(4):1020-7. PubMed ID: 10520784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.
    Bijsterveld NR; Moons AH; Meijers JC; Tijssen JG; Büller HR; Levi M; Peters RJ
    J Am Coll Cardiol; 2002 Mar; 39(5):811-7. PubMed ID: 11869846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study. Thrombin inhibition in Myocardial Ischaemia (TRIM) study group.
    Eur Heart J; 1997 Sep; 18(9):1416-25. PubMed ID: 9458447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.
    Bahit MC; Topol EJ; Califf RM; Armstrong PW; Criger DA; Hasselblad V; Betriu A; Hirsh J; Ardissino D; Granger CB
    J Am Coll Cardiol; 2001 Mar; 37(4):1001-7. PubMed ID: 11263599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
    Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes.
    Di Nisio M; Bijsterveld NR; Meijers JC; Levi M; Büller HR; Peters RJ
    J Am Coll Cardiol; 2005 Oct; 46(8):1582-3. PubMed ID: 16226189
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease.
    Linder R; Oldgren J; Egberg N; Grip L; Larson G; Siegbahn A; Wallentin L
    Eur Heart J; 1999 Apr; 20(7):506-18. PubMed ID: 10365287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty.
    Smith AJ; Holt RE; Fitzpatrick JB; Palacios IF; Gold HK; Werner W; Bovill EG; Fuster V; Jang IK
    Am Heart J; 1996 Mar; 131(3):434-9. PubMed ID: 8604621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.
    Sloan MA; Price TR; Petito CK; Randall AM; Solomon RE; Terrin ML; Gore J; Collen D; Kleiman N; Feit F
    Neurology; 1995 Apr; 45(4):649-58. PubMed ID: 7723950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin management in acute myocardial infarction (AMI).
    Granger CB
    Aust N Z J Med; 1998 Aug; 28(4):541-7. PubMed ID: 9777136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy.
    Goodman SG; Barr A; Sobtchouk A; Cohen M; Fromell GJ; Laperrière L; Hill C; Langer A
    J Am Coll Cardiol; 2000 Nov; 36(5):1507-13. PubMed ID: 11079650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early reactivation of ischaemia after abrupt discontinuation of heparin in acute myocardial infarction.
    Di Tano G; Mazzù A
    Br Heart J; 1995 Aug; 74(2):131-3. PubMed ID: 7546990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
    Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes.
    Valgimigli M; Frigoli E; Leonardi S; Rothenbühler M; Gagnor A; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andò G; Repetto A; Limbruno U; Garbo R; Sganzerla P; Russo F; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Presbitero P; Santarelli A; Sardella G; Varbella F; Tresoldi S; de Cesare N; Rigattieri S; Zingarelli A; Tosi P; van 't Hof A; Boccuzzi G; Omerovic E; Sabaté M; Heg D; Jüni P; Vranckx P;
    N Engl J Med; 2015 Sep; 373(11):997-1009. PubMed ID: 26324049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.